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A historical perspective of registered cases of malignant ocular 
tumors in Zimbabwe (1990 to 1999). Is HIV infection a factor?
*R MASANGANISE, *S RUSAKANIKO, *R MAKUNIKE, *M HOVE, *E CHOKUNONGA, *MZ BOROK, 
*BG MAUCHAZA, *MZ CHIRENJE, *VN MASANGANISE, **T MAGURE
Abstract
Introduction: Anecdotal and published reports suggest that ocular tumours are on the increase in Zimbabwe. 
Objectives: To determine the trends in incidence rates of common malignant ocular tumours registered with 
the Zimbabwe Cancer Registry during the last decade (1990 to 1999).
Design: Retrospective study.
Setting: Data were collected from the Zimbabwe National Cancer Registry, the Zimbabwe National Census 
1992 and 2002 Reports, and patient records from hospitals.
Subjects: All cases of malignant ocular tumours registered with the Zimbabwe National Cancer Registry 
between 1 January 1990 and 31 December 1999.
Main Outcome Measures: Age standardized annual incidence rates for registered cases of common ocular 
tumours.
Results: The age-adjusted annual incidence rates of squamous cell carcinoma of the conjunctiva had a more 
than 10-fold increase from 0.17 to 1.8 per 100 000 people during periods 1990 and 1999 respectively. 
Retinoblastoma dropped by more than half from 0.8 to 0.34 per 100 000 during the same period. The annual 
age standardised incidence rates for all ocular tumours showed a significant upward linear trend (% '■ 362.78, 
df = 9 and p<0.001). There was no significant gender difference in the distribution of these tumours amongst 
the study population.
Conclusion: The increasing trend in the age-adjusted annual incidence rates of ocular surface squamous 
neoplasms could be attributed to the worsening HIV and AIDS pandemic in Zimbabwe or improved 
access/utilization of health services by the public.
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Introduction
In 1998 the Zimbabwe National Cancer Registry 
ranked eye tumours as the sixth commonest group of 
tumours reported in Zimbabwe (3.9%). The leading 
tumours included Kaposi's sarcoma ( 26%), cervical 
and uterine tumours (23%), non-melanoma tumours of 
the skin (12%), breast tumours (9%) and prostatic 
tumours (8%) respectively. These data were striking, 
since the proportion of eye tumours among all 
registered tumours for 1998 o f 4% had more than 
trebled the 1990 proportion o f 1.2%.' Work done by 
Chokunonga and colleagues in 1999 showed a 
dramatic increase in the number o f reported cases o f  
squamous cell carcinoma o f the conjunctiva between 
1993 and 1995.2 A retrospective study conducted by 
Pola and colleagues on ocular surface squamous 
neoplasia (OSSN) seen at Sekuru Kaguvi Eye Unit
(SKEU) showed that the annual frequency o f  
squamous cell carcinomas o f the conjunctiva among 
conjunctival biopsies rose from 33% in 1996 to 58% in 
the year 2000.3
Published studies have found a higher incidence of 
squamous cell carcinoma in patients with HIV and 
AIDS.4'5 Two Australian retrospective studies found 
that older males were predominantly affected by ocular 
surface squamous neoplasia (including invasive 
squamous cell carcinoma).67 Retrospective studies 
done in Africa on tumours o f the eye and adnexae have 
shown that squamous cell carcinoma of the conjunctiva 
and retinoblastoma are the leading malignant tumours 
affecting these tissues.8-"
Information on the trends o f ocular tumours over a 
decade is o f immense value in a number o f ways. 
Namely: when assessing the impact o f an intervention 
on the incidence rates o f tumours, when predicting the
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magnitude o f the problem in the future and when 
determining the effect o f emerging diseases like HIV 
and AIDS on the tumours. Unfortunately published 
studies from Africa did not address the historical 
perspective on patterns o f  incidences o f common 
ocular tumours in their settings.8-11
The aim o f this study was to determine the patterns o f  
annual incidence rates o f  the two commonest registered 
malignant ocular tumours in Zimbabwe during the 
period 1 January 1990 to 31 December 1999.
Materials and Methods
Data was obtained from the Zimbabwe National 
Cancer Registry and hospital records using purpose 
designed data collection tools which captured the 
following information:
(1) Patient details included patient names, age, gender, 
residential address, race, occupation and national 
registration number.
(2) Tumour details included date o f  diagnosis, 
histology report, duration o f symptoms, site o f primary 
tumour, stage o f tumour and treatment received.
(3) Institution details included name and address o f  
reporting hospital, hospital number, ward and source o f  
information.
Estimates o f annual population figures for the various 
age groups in Zimbabwe were based on inter-census 
projections from the years 1992 and 2002 national 
census figures and these were used to calculate the 
annual incidence rates.12'13
Data Analysis.
A direct method o f standardizing the incidence rates 
was employed using the latest Zimbabwe National 
Census population figures as o f the night o f 17/18 
August, 2002.13 The age-adjusted rate for each year was 
calculated using the formula:
Age adjusted rate  =  Sum (age specific rate x  
proportion o f  standard population in age category)'4 
Chi-squared tests for age-standardized rates over the 
10 year period were calculated and their p values 
determined. The total population for the year 2002 was 
used with age groupings (zero to five, six tolO, 11 to 15, 
etc) for calculating the age-standardised annual 
incidence rates for squamous cell carcinomas, while 
the zero to 10 year age group population was used for 
retinoblastomas.15
Results
A total o f  1 741 patients with malignant ocular tumours 
were registered with the Zimbabwe National Cancer 
Register between .1 January 1990 and 31 December 
1999. O f these patients 1 226 (71%) had squamous cell 
carcinomas o f the conjunctiva, while 209 (12%) had 
retinoblastomas; 38 (2%) had Kaposi's sarcoma o f  the 
eye lids and the rest had various other malignant 
tumours o f the eye. (See Figure I)
Figure I: Tumor distribution by histology diagnosis.
ossn- ocular surface squamous neoplasia; Ret 
Retinoblastoma; K S Kaposi's Sarcoma.
The trend o f age-adjusted annual incidence rates o f the 
top two registered ocular tumours in Zimbabwe is 
illustrated in Figure II.
Figure II: Age adjusted incidence rates fo r  common 
malignant ocular tumours in Zimbabwe.
Scca: squamous cell carcinoma o f the conjunctiva /100 
000people: (age-adjusted rates), 
ret: retinoblastoma o f the eye/100 000 children: 0 to 10 
years o f age (age-adjusted rates).
The age-adjusted incidence rate for registered 
squamous cell carcinomas o f the eye between 1990 and 
1999 demonstrated a more than 10-fold increase (from
0.17 to 1.8 per 100 000 people respectively), whereas 
the retinoblastoma age-adjusted incidence rates for the 
same period showed a decrease o f more than 50% 
(from 0.8 to 0.34 per 100 000 children below 10 years 
o f age respectively).
The age-standardised annual incidence rates for all 
registered ocular tumours grouped together showed a 
positive upward linear trend (y2:362.78, with 9df and 
p<0.001). However, the age-standardised annual 
incidence rates for registered retinoblastomas showed
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significant downward linear trend during the period 
under study(x2 : 8.404, with 9df and p value o f
0.00374).
The distribution o f all registered tumours by gender 
has been summarized in Figure III below.
Figure III: Distribution o f  all registered ocular 
tumours by gender.
There were no significant gender differences on the 
age-adjusted incidence rates for both squamous cell 
carcinoma o f the conjunctiva and retinoblastomas 
combined (X2:17.29, with 9df and p value o f (0.04) as 
represented in Figure III. Figure IV is a graphical 
illustration o f age-adjusted incidence rates for 
squamous cell carcinoma o f the conjunctiva by gender.
Figure: IV Age adjusted incidence rates o f squamous 
cell carcinomas in Zimbabwe by gender.
Discussion
A number o f studies have looked at the patterns and 
incidence o f malignant ocular tumours in various 
African countries in the past,8'’ Recent studies 
conducted in Congo Kinshasa'6 and Singapore” have 
shown that the leading ocular tumours differ front one 
country to another. In Congo Kinshasa, the leading
ocular tumours were: epidermoid squamous cell 
carcinoma o f the eye (34 %), retinoblastomas (32%) 
and metastatic tumours. In Singapore retinoblastomas 
(54%), melanoma o f the eye (19%) and squamous cell 
carcinoma o f the eye topped the list. These patterns are 
different from what is experienced in Zimbabwe where 
squamous cell carcinomas o f  the conjunctiva (70.3%), 
retinoblastomas (12.3%) and Kaposi's sarcoma (2.2%) 
are the leading ocular tumours. Factors contributing to 
the variation in ocular tumour types among different 
countries may include the following: race, ethnic 
origin, socio-cultural factors, disease patterns (HIV 
infections in particular), climatic conditions and 
availability o f health services.
Traditionally, SCCA o f the conjunctiva has a 
predilection for males and affects the older age group 
(late forties and above) and this has been supported by 
studies done in Uganda and Sudan before the advent of  
HIV infection, and recently in Australia.6’89 However, 
this traditional way o f presentation o f SCCA of 
conjunctiva has not been observed in Zimbabwe where 
this disease was virtually unknown during the early 
1980's but has now become the commonest registered 
ocular cancer affecting a younger age group and having 
no gender predilection.
Recent studies conducted locally have established 
that squamous cell carcinoma o f the conjunctiva is the 
leading tumour necessitating enucleations and orbital 
exenterations at Sekuru Kaguvi Eye Unit (SKEU) in 
Zimbabwe.'8’19 The increase in the number o f patients 
suffering from SCCA of the conjunctiva has been 
confirmed among Ugandans, Malawians and 
Tanzanians and has been attributed to the AIDS 
pandemic with the background o f solar radiation.2" 22 
Although squamous cell carcinoma o f the conjunctiva 
is now recognised as an AIDS related cancer in sub- 
Saharan Africa23 and South Africa,24 further studies on 
the aetiology o f these tumours are mandatory if 
appropriate preventive measures are to be instituted.
The age-adjusted annual incidence rate of all 
registered malignant ocular tumours in Zimbabwe has 
increased by more than three-fold from 0.69 to 2.56 
cases per 100 000 people between 1990 and 1999 
respectively. This increase has been largely due to* an 
epidemic o f squamous cell carcinoma o f the 
conjunctiva. However, the age-adjusted incidence rate 
for retinoblastomas in Zimbabwe has dropped by more 
than 50% during the same period o f study as illustrated 
in Figure II. These observations suggest the presence of 
some factor which increases the risk o f developing 
SCCA o f the conjunctiva among Zimbabweans, while 
it has no effect, on the risk o f  developing 
retinoblastomas, thus eliminating the possibility of 
improved access to health facilities as an explanation 
for the apparent increases in incidence rates. The 
exposure to the factor could have been in the late 19S0's 
a id early nineties since SCCA o f the conjunctiva had 
not be n reported before then in Zimbabwe. This 
happens to coincide with the onset o f the HIV and the 
AIDS epidemic here. Although the design o f our study
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Referencesdid not accommodate HIV tests and CD4 cell counts 
the onset and observed increased incidence rates of 
SCCAof the conjunctiva in Zimbabwe parallel the HIV 
and AIDS pandemic being experienced here, thus 
implicating HIV infection in the aetiology o f this 
condition.
It is important to note that these incidence rates are 
conservative estimates since many patients still 
patronize non-conventional/traditional medicine. 
Some object to investigations and surgery, while others 
may not have been registered with the Cancer Registry 
for other reasons. The age group affected by SCCA of  
conjunctiva comprises the country's labour force. The 
increase in the incidence o f  this tumour coupled with 
the high mortality rate is causing loss o f the much 
needed labour force, an increasing the number o f  
orphans and over-stretching limited health resources in 
an attempt to provide these patients with some form o f  
care.
This study has confirmed the changing patterns o f  
SCCA of the conjunctiva from a tumour which usually 
affects elderly males who engaged in outdoor work19 to 
a tumour which has no gender predilection, affects 
young people o f child-bearing age, is highly malignant 
and is not a ssocia ted  w ith the nature o f  
employment.'415,25
These findings are of immense value since they will 
form baseline data for comparison in subsequent 
studies of a similar nature and pose challenges 
regarding the etiology o f squamous cell carcinomas of 
the conjunctiva in Zimbabwe. It is important to note 
that the design o f the study (secondary data analysis) 
narrowed the scope o f data utilization. Irregularities 
like incomplete notification forms (address code, age, 
gender) could not be rectified and the incidence rates 
calculated are likely to be lower than true rates for 
reasons elaborated earlier on.
Conclusion
This study has shown that SCCA of the conjunctiva is 
now the commonest registered ocular tumour in 
Zimbabwe and its age-adjusted incidence rate is on the 
increase. Although the causative agent for SCCA of 
conjunctiva is still speculative, evidence gathered in 
this study cannot exonerate exposure to HIV infection 
on the basis o f absent laboratory tests. The current 
magnitude of the problem as compared to the nineteen 
eighties warrants it being classified as a local epidemic 
and this may assist resource mobilisation geared 
towards appropriate interventions in this country.
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